Back to search
Metastatic Prostate Adenocarcinoma With Neuroendocrine Differentiation
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Metastatic Prostate Adenocarcinoma With Neuroendocrine Differentiation trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Metastatic Prostate Adenocarcinoma With Neuroendocrine Differentiation trials you may qualify forThis phase II trial studies how well lutetium Lu 177 dotatate works in treating patients with prostate cancer with neuroendocrine differentiation that has sprea…
The objective of this study is to evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of BL-M14D1 in Subjects with locally Advanced or Metastatic…
This study is a prospective, single arm II clinical trial. The main objective of the study is to evaluate the efficacy and safety of the combination of Sacituzu…
This randomized phase II trial studies how well olaparib with or without cediranib works in treating patients with castration-resistant prostate cancer that has…
This phase I trial investigates the side effects of cabozantinib and nivolumab in treating patients with cancer that may have spread from where it first started…